Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2016 07:00 ET | Source: Abiomed

Abiomed Announces Q2 FY 2017 Revenue of $103 Million, Up 35% Over Prior Year

- Impella® Heart Pumps Assigned to Heart Assist System Implant, MS-DRG 215 DANVERS, Mass., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough...
October 25, 2016 16:00 ET | Source: Abiomed

Abiomed’s Impella Technology Showcased at TCT 2016 With More Than 25 Presentations During Scientific Sessions

DANVERS, Mass., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Abiomed Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, announces that there are more than 25 presentations...
October 06, 2016 08:39 ET | Source: Abiomed

Avis annonçant la conférence téléphonique et la publication des résultats du deuxième trimestre de l'exercice 2017 d'Abiomed

DANVERS, Massachussetts, le 6 octobre 2016 (GLOBE NEWSWIRE) - Abiomed, Inc. (NASDAQ : ABMD) annonce que le jeudi 27 octobre 2016, la Société publiera ses résultats financiers du deuxième trimestre...
October 06, 2016 08:39 ET | Source: Abiomed

Abiomed gibt die Geschäftsergebnisse für das zweite Quartal des Geschäftsjahres 2017 bekannt und kündigt Telefonkonferenz an

DANVERS, Massachusetts, USA, 6. Okt. 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) gab bekannt, dass das Unternehmen am Donnerstag, dem 27. Oktober 2016, die Geschäftsergebnisse für das...
October 06, 2016 08:01 ET | Source: Abiomed

Abiomed Second Quarter Fiscal 2017 Earnings and Conference Call Notification

DANVERS, Mass., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, October 27, 2016, the Company will release financial results for the second quarter of...
September 27, 2016 07:53 ET | Source: Abiomed

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

DANVERS, Mass., Sept. 27, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, announced today that the Impella 2.5 and Impella 5.0...
July 28, 2016 07:00 ET | Source: Abiomed

Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year

DANVERS, Mass., July 28, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2017 revenue of...
July 07, 2016 08:00 ET | Source: Abiomed

Abiomed First Quarter Fiscal 2017 Earnings and Conference Call Notification

DANVERS, Mass., July 07, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, July 28, 2016, the Company will release financial results for the first quarter of fiscal...
June 07, 2016 08:00 ET | Source: ABIOMED, Inc.

Abiomed to Present at the William Blair 2016 Growth Stock Conference

DANVERS, Mass., June 07, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
June 03, 2016 09:00 ET | Source: ABIOMED, Inc.

Abiomed to Present at the Jefferies 2016 Healthcare Conference

DANVERS, Mass., June 03, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...